PROPANC BIOPHARMA, INC. Adjustments to Additional Paid in Capital, Warrant Issued
PROPANC BIOPHARMA, INC. (PPCB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $1.80 thousand for the 3-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2026-03-31 was $1.80K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-09-30 was $2.41K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-09-30 was $20.72K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-12-31 was $984.81K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $2.41K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $984.81K.
- PROPANC BIOPHARMA, INC. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $47.56K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2026-03-31 | $1.80K S-1 · filed 2026-07-17 | |
| 2023-06-30 | $2.41K 10-K · filed 2024-09-30 | |
| 2022-09-30 | $2.41K 10-Q · filed 2024-05-15 | |
| 2020-09-30 | $20.72K 10-Q · filed 2022-05-16 | |
| 2020-06-30 | $984.81K 10-K · filed 2021-09-28 | |
| 2019-12-31 | $984.81K 10-Q · filed 2020-05-15 | |
| 2016-06-30 | $47.56K 10-K · filed 2017-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |